Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy
Susan Furness(University of Manchester), David I. Conway(University of Glasgow), Sue Pavitt(University of Leeds), Helen V Worthington(University of Manchester), Richard Oliver(Shrewsbury College), Anne‐Marie Glenny(University of Manchester), Kelvin Chan, Jan Clarkson(University of Dundee), Michaelina Macluskey(University of Dundee)
Cited by 183
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors
|BDJ|2022|706
Socioeconomic inequalities and oral cancer risk: A systematic review and meta‐analysis of case‐control studies
|International Journal of Cancer|2008|436